Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 798 | 930 | 891 | 780 | 2,917 |
| Cost of Goods | 552 | 634 | 660 | 701 | 1,648 |
| Gross Profit | 245 | 296 | 231 | 79 | 1,269 |
| Operating Expenses | 4,144 | 4,547 | 4,680 | 4,951 | 4,777 |
| Operating Income | -3,347 | -3,618 | -3,789 | -4,171 | -2,859 |
| Other Income | 5,196 | -876 | 2,659 | 556 | -255 |
| Pre-tax Income | 1,850 | -4,494 | -1,130 | -3,616 | -3,114 |
| Net Income Continuous | 1,850 | -4,494 | -1,130 | -3,616 | -3,114 |
| Minority Interests | -30 | -23 | -25 | -23 | -14 |
| Net Income | $1,880 | $-4,471 | $-1,105 | $-3,592 | $-3,100 |
| EPS Basic Total Ops | 0.47 | -5.31 | -1.80 | -5.31 | -4.80 |
| EPS Basic Continuous Ops | 0.46 | -5.16 | -1.65 | -5.40 | -4.83 |
| EPS Diluted Total Ops | 0.47 | -5.31 | -1.80 | -5.31 | -4.80 |
| EPS Diluted Continuous Ops | 0.46 | -5.16 | -1.65 | -5.40 | -4.83 |
| EPS Diluted Before Non-Recurring Items | 0.47 | -5.31 | -1.80 | -5.20 | -4.80 |
| EBITDA(a) | $-3,213 | $-3,431 | $-3,490 | $-3,842 | $-2,510 |